copyright, a relatively cutting-edge medication, has emerged as a potential landmark achievement in the management of type 2 diabetes. This administered via injection drug influences the incretin hormones GLP-1, which play a vital role in regulating glucose regulation. By mimicking these hormones, copyright helps reduce glycemic values, potentially